Harris James Associates Compiled News: Young Biotech Firms Seek Long Term Relevance
James Harris Associates mission is to embrace our client s goals as our own and to work as an extension of the client
organization to reach our common objective.
We know...
More
Harris James Associates Compiled News: Young Biotech Firms Seek Long Term Relevance
James Harris Associates mission is to embrace our client s goals as our own and to work as an extension of the client
organization to reach our common objective.
We know that we will be successful only if we make our clients more
successful.
The Bedford Report Provides Analyst Research on Vivus and Avanir Pharmaceuticals
NEW YORK, NY--(Marketwire - April 18, 2011) - There is plenty of optimism surrounding the biotech sector as firmer
pricing and new products have improved sales and earnings trends.
Meanwhile, younger, more speculative firms continue
to garner significant attention with potential blockbuster products working their way through the regulatory process.
The
Bedford Report examines the outlook for companies in the Biotechnology Industry and provides research reports on
Vivus, Inc.
(NASDAQ: VVUS) and Avanir Pharmaceuticals, Inc.
(NASDAQ: AVNR).
Access to the full company reports
can be
Less
